+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Implantable Insulin Pump Market by Type, Disease, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • ID: 5457319
  • Report
  • August 2021
  • Region: Global
  • 195 Pages
  • Allied Analytics LLP

FEATURED COMPANIES

  • Apex Medical
  • CVS Health (Aetna Inc.)
  • Diabeloop
  • Diamesco Co. Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation
The global implantable insulin pump market was valued at $2,674 million in 2020, and is projected to reach $6,443 million by 2030, registering a CAGR of 9.1% from 2021 to 2030.



Implantable insulin pump is a medical device that helps in delivering insulin into peritoneal cavity, and remains inside the human body all the time. Moreover, implanted insulin pumps aids in effective absorption of insulin. The implantable insulin pumps are projected to revolutionize the treatment of diabetes disease and also gives a constructive solution for accurately effective artificial pancreas. There are two types of implantable insulin pump such as closed-loop insulin pump and open-loop insulin pump. It is a next generation insulin that automatically responds to changing blood glucose levels. Moreover, it is a painless mode of delivering insulin compared to injectable insulin, minimizing the risk of skin irritation caused due to needles.

The growth of the implantable insulin pump market is driven by rise in prevalence of diabetes across the globe, increase in demand for implantable insulin pump, and accuracy in dosage delivery of insulin by implantable insulin pump. In addition, awareness about insulin treatment by healthcare professionals, technological advancements in implantable insulin pump, rise in patient emphasis on effective & early diabetes disease treatment, and increase in investment in R&D for insulin pumps are expected to boost the market growth during the forecast period. However, stringent government regulations expected to hamper the market growth during the forecast period. Conversely, high market growth potential in emerging markets is expected to offer lucrative opportunities during the forecast period.

The implantable insulin pump market is segmented on the basis of type, disease, end user, and region. On the basis of type, the market is categorized into closed-loop insulin pump and open-loop insulin pump. By disease, the market is divided into type 1 diabetes and type 2 diabetes. On the basis of end user, the market is categorized into hospitals and home care. The hospitals segment is further segmented into type 1 diabetes and type 2 diabetes. The home care segment is further segmented into type 1 diabetes and type 2 diabetes. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

  • The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers a quantitative analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
  • A comprehensive analysis of four regions is provided to determine the existing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS


By Type

  • Closed-Loop Insulin Pump
  • Open-Loop Insulin Pump

By Disease

  • Type 1 Diabetes
  • Type 2 Diabetes

By End User

  • Hospitals
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Home Care
  • Type 1 Diabetes
  • Type 2 Diabetes

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Apex Medical
  • CVS Health (Aetna Inc)
  • Diabeloop
  • Diamesco Co., Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • SOOIL Developments Co. Ltd
  • Tandem Diabetes Care
Frequently Asked Questions about the Global Implantable Insulin Pump Market

What is the estimated value of the Global Implantable Insulin Pump Market?

The Global Implantable Insulin Pump Market was estimated to be valued at $2674.0 million in 2020.

What is the growth rate of the Global Implantable Insulin Pump Market?

The growth rate of the Global Implantable Insulin Pump Market is 9.2%, with an estimated value of $6443.0 million by 2030.

What is the forecasted size of the Global Implantable Insulin Pump Market?

The Global Implantable Insulin Pump Market is estimated to be worth $6443.0 million by 2030.

Who are the key companies in the Global Implantable Insulin Pump Market?

Key companies in the Global Implantable Insulin Pump Market include Apex Medical, CVS Health (Aetna Inc.), Diabeloop, Diamesco Co. Ltd, F. Hoffmann La Roche Ltd, Insulet Corporation, Johnson & Johnson, Medtronic Plc and Tandem Diabetes Care.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Apex Medical
  • CVS Health (Aetna Inc.)
  • Diabeloop
  • Diamesco Co. Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of diabetes worldwide
3.5.1.2. Sedentary and unhealthy lifestyle pattern
3.5.1.3. Increase in government expenditure on healthcare
3.5.2. Restraint
3.5.2.1. Stringent government regulations
3.5.3. Opportunities
3.5.3.1. High market growth potential in emerging markets
3.5.4. Impact analysis
3.6. Covid-19 Impact analysis on implantable insulin pump market

CHAPTER 4: IMPLANTABLE INSULIN PUMP MARKET, BY TYPE

4.1. Overview
4.1.1. Market size and forecast
4.2. Closed-loop insulin pump
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. Open-loop insulin pump
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

CHAPTER 5: IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE

5.1. Overview
5.1.1. Market size and forecast
5.2. Type 1 diabetes
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Type 2 diabetes
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country

CHAPTER 6: IMPLANTABLE INSULIN PUMP MARKET, BY END USER

6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.2.3. Market size and forecast, by disease
6.3. Home care
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.3.3. Market size and forecast, by disease

CHAPTER 7: IMPLANTABLE INSULIN PUMP MARKET, BY REGION

7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
U.S. implantable insulin pump market, by type
U.S. implantable insulin pump market, by disease
U.S. implantable insulin pump market, by end user
7.2.2.2. Canada
Canada implantable insulin pump market, by type
Canada implantable insulin pump market, by disease
Canada implantable insulin pump market, by end user
7.2.2.3. Mexico
Mexico implantable insulin pump market, by type
Mexico implantable insulin pump market, by disease
Mexico implantable insulin pump market, by end user
7.2.3. North America market size and forecast, by type
7.2.4. North America market size and forecast, by disease
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
Germany implantable insulin pump market, by type
Germany implantable insulin pump market, by disease
Germany implantable insulin pump market, by end user
7.3.2.2. France
France implantable insulin pump market, by type
France implantable insulin pump market, by disease
France implantable insulin pump market, by end user
7.3.2.3. UK
UK implantable insulin pump market, by type
UK implantable insulin pump market, by disease
UK implantable insulin pump market, by end user
7.3.2.4. Italy
Italy implantable insulin pump market, by type
Italy implantable insulin pump market, by disease
Italy implantable insulin pump market, by end user
7.3.2.5. Spain
Spain implantable insulin pump market, by type
Spain implantable insulin pump market, by disease
Spain implantable insulin pump market, by end user
7.3.2.6. Rest of Europe
Rest of Europe implantable insulin pump market, by type
Rest of Europe implantable insulin pump market, by disease
Rest of Europe implantable insulin pump market, by end user
7.3.3. Europe market size and forecast, by type
7.3.4. Europe market size and forecast, by disease
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
Japan implantable insulin pump market, by type
Japan implantable insulin pump market, by disease
Japan implantable insulin pump market, by end user
7.4.2.2. China
China implantable insulin pump market, by type
China implantable insulin pump market, by disease
China implantable insulin pump market, by end user
7.4.2.3. Australia
Australia implantable insulin pump market, by type
Australia implantable insulin pump market, by disease
Australia implantable insulin pump market, by end user
7.4.2.4. India
India implantable insulin pump market, by type
India implantable insulin pump market, by disease
India implantable insulin pump market, by end user
7.4.2.5. South Korea
South Korea implantable insulin pump market, by type
South Korea implantable insulin pump market, by disease
South Korea implantable insulin pump market, by end user
7.4.2.6. Rest of Asia-Pacific
Rest of Asia-Pacific implantable insulin pump market, by type
Rest of Asia-Pacific implantable insulin pump market, by disease
Rest of Asia-Pacific implantable insulin pump market, by end user
7.4.3. Asia-Pacific market size and forecast, by type
7.4.4. Asia-Pacific market size and forecast, by disease
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
Brazil implantable insulin pump market, by type
Brazil implantable insulin pump market, by disease
Brazil implantable insulin pump market, by end user
7.5.2.2. Saudi Arabia
Saudi Arabia implantable insulin pump market, by type
Saudi Arabia implantable insulin pump market, by disease
Saudi Arabia implantable insulin pump market, by end user
7.5.2.3. South Africa
South Africa implantable insulin pump market, by type
South Africa implantable insulin pump market, by disease
South Africa implantable insulin pump market, by end user
7.5.2.4. Rest of LAMEA
Rest of LAMEA implantable insulin pump market, by type
Rest of LAMEA implantable insulin pump market, by disease
Rest of LAMEA implantable insulin pump market, by end user
7.5.3. LAMEA market size and forecast, by type
7.5.4. LAMEA market size and forecast, by disease
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Apex Medical
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.2. CVS Health (Aetna Inc.)
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.3. Diabeloop SACA
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Key strategic moves and developments
8.4. DIAMESCO CO., LTD.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.5. F. Hoffmann La Roche Ltd.
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. Insulet Corporation
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. Johnson & Johnson
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. Medtronic PLC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. Sooil Developments Co. Ltd.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. Tandem Diabetes Care Inc.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

List of Tables
TABLE 01. IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 02. CLOSED-LOOP INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. CHIMERIC IMPLANTABLE INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 05. IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 1 DIABETES, BY REGION, 2020-2030 ($MILLION)
TABLE 06. IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 2 DIABETES, BY REGION, 2020-2030 ($MILLION)
TABLE 07. IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 08. IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY REGION, 2020-2030 ($MILLION)
TABLE 09. IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY DISEASE, 2020-2030 ($MILLION)
TABLE 10. IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY REGION, 2020-2030 ($MILLION)
TABLE 11. IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY DISEASE, 2020-2030 ($MILLION)
TABLE 12. IMPLANTABLE INSULIN PUMP MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 13. NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 14. U.S. IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 15. U.S. IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 16. U.S. IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 17. CANADA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 18. CANADA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 19. CANADA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 20. MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 21. MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 22. MEXICO IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 23. NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 24. NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 25. NORTH AMERICA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 26. EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 27. GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 28. GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 29. GERMANY IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 30. FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 31. FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 32. FRANCE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 33. UK IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 34. UK IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 35. UK IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 36. ITALY IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 37. ITALY IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 38. ITALY IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 39. SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 40. SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 41. SPAIN IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 42. REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 43. REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 44. REST OF EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 45. EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 46. EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 47. EUROPE IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 48. ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 49. JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 50. JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 51. JAPAN IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 52. CHINA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 53. CHINA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 54. CHINA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 55. AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 56. AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 57. AUSTRALIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 58. INDIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 59. INDIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 60. INDIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 61. SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 62. SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 63. SOUTH KOREA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 67. ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 68. ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 69. ASIA-PACIFIC IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 70. LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 71. BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 72. BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 73. BRAZIL IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 74. SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 75. SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 76. SAUDI ARABIA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 77. SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 78. SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 79. SOUTH AFRICA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 80. REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 81. REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 82. REST OF LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 83. LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 84. LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY DISEASE, 2020-2030 ($MILLION)
TABLE 85. LAMEA IMPLANTABLE INSULIN PUMP MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 86. APEX MEDICAL: COMPANY SNAPSHOT
TABLE 87. APEX MEDICAL: OPERATING SEGMENTS
TABLE 88. APEX MEDICAL: PRODUCT PORTFOLIO
TABLE 89. CVS HEALTH (ATENA INC).: COMPANY SNAPSHOT
TABLE 90. CVS HEALTH (AETNA INC).: OPERATING SEGMENTS
TABLE 91. CVS HEALTH (AETNA INC.): PRODUCT PORTFOLIO
TABLE 92. DIABELOOP SACA: COMPANY SNAPSHOT
TABLE 93. DIABELOOP SACA: OPERATING SEGMENTS
TABLE 94. DIABELOOP SACA: PRODUCT PORTFOLIO
TABLE 95. DIABELOOP SACA.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 96. DIAMESCO: COMPANY SNAPSHOT
TABLE 97. DIAMESCO: OPERATING SEGMENTS
TABLE 98. DIAMESCO: PRODUCT PORTFOLIO
TABLE 99. F. HOFFMANN LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 100. F. HOFFMANN LA ROCHE LTD: OPERATING SEGMENTS
TABLE 101. F. HOFFMANN LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 102. F. HOFFMANN LA ROCHE LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. INSULET CORPORATION: COMPANY SNAPSHOT
TABLE 104. INSULET CORPORATION: OPERATING SEGMENTS
TABLE 105. INSULET CORPORATION: PRODUCT PORTFOLIO
TABLE 106. INSULET CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107. JOHNSON & JOHNSON: COMPANY SNAPSHOT
TABLE 108. JOHNSON & JOHNSON: OPERATING SEGMENTS
TABLE 109. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 110. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 111. MEDTRONIC PLC: OPERATING SEGMENTS
TABLE 112. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 113. MEDTRONIC PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 114. SOOIL DEVELOPMENTS CO. LTD.: COMPANY SNAPSHOT
TABLE 115. SOOIL DEVELOPMENTS CO. LTD.: OPERATING SEGMENTS
TABLE 116. SOOIL DEVELOPMENTS CO. LTD.: PRODUCT PORTFOLIO
TABLE 117. SOOIL DEVELOPMENTS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118. TANDEM DIABETES CARE INC.: COMPANY SNAPSHOT
TABLE 119. TANDEM DIABETES CARE INC.: OPERATING SEGMENTS
TABLE 120. TANDEM DIABETES CARE INC: PRODUCT PORTFOLIO
TABLE 121. TANDEM DIABETES CARE INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS

List of Figures
FIGURE 01. IMPLANTABLE INSULIN PUMP MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 01. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 02. MODERATE BARGAINING POWER OF BUYERS
FIGURE 03. MODERATE THREAT OF SUBSTITUTES
FIGURE 04. LOW THREAT OF NEW ENTRANTS
FIGURE 05. HIGH INTENSITY OF RIVALRY
FIGURE 06. TOP PLAYER POSITIONING, 2020
FIGURE 07. IMPACT ANALYSIS
FIGURE 08. COMPARATIVE ANALYSIS OF CLOSED-LOOP INSULIN PUMP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 09. COMPARATIVE ANALYSIS OF CHIMERIC IMPLANTABLE INSULIN PUMP MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 10. COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 1 DIABETES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 11. COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR TYPE 2 DIABETES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 12. COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR HOSPITALS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 13. COMPARATIVE ANALYSIS OF IMPLANTABLE INSULIN PUMP MARKET FOR HOME CARE, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. CVS HEALTH (ATENA INC).: NET SALES, 2018-2020 ($MILLION)
FIGURE 15. F. HOFFMANN LA ROCHE LTD: NET SALES, 2018-2020 ($MILLION)
FIGURE 16. INSULET CORPORATION: NET SALES, 2017-2019 ($MILLION)
FIGURE 17. INSULET CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 18. INSULET CORPORATION: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 19. JOHNSON & JOHNSON: NET SALES, 2018-2020 ($MILLION)
FIGURE 20. JOHNSON & JOHNSON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 21. JOHNSON & JOHNSON: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 22. MEDTRONIC PLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 23. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 25. TANDEM DIABETES CARE INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 26. TANDEM DIABETES CARE INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
Note: Product cover images may vary from those shown
  • Apex Medical
  • CVS Health (Aetna Inc.)
  • Diabeloop
  • Diamesco Co. Ltd
  • F. Hoffmann La Roche Ltd
  • Insulet Corporation
  • Johnson & Johnson
  • Medtronic Plc
  • SOOIL Developments Co. Ltd
  • Tandem Diabetes Care
Note: Product cover images may vary from those shown

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Adroll
adroll